ArticleThe Journal of allergy and clinical immunology2025
Engineering nanoallergens to investigate origins of immunogenicity and cross-reactivity in cephalosporin allergy.
Emily K Bromley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.